Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.5K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.5K
Oogenesis02:07

Oogenesis

58.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.4K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

5.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
5.1K
Menses Phase01:18

Menses Phase

1.5K
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026
Same author

Shrinking Pipelines and Shifting Priorities: An Analysis of the 2019-2025 Pain Medicine Fellowship Match.

Pain medicine (Malden, Mass.)·2026
Same author

Emergency physicians in pain medicine: Workforce trends, competency overlap, gaps, and opportunities for integration.

Interventional pain medicine·2026
Same author

Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis.

Cephalalgia : an international journal of headache·2024
Same author

Case-based peer teaching for pain medicine fellows: a curriculum for diverse residency backgrounds.

Pain medicine (Malden, Mass.)·2024
Same author

Current state of the pain medicine match: perspective and an eye to the future.

Regional anesthesia and pain medicine·2024
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Related Experiment Video

Updated: Apr 30, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

19.1K

Migraine and estrogen.

Nu Cindy Chai1, B Lee Peterlin, Anne H Calhoun

  • 1aDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland bCarolina Headache Institute, University of North Carolina, Chapel Hill, North Carolina, USA.

Current Opinion in Neurology
|May 6, 2014
PubMed
Summary
This summary is machine-generated.

Migraine is more common in women due to estrogen level fluctuations. Minimizing estrogen drops may prevent menstrually related migraine (MRM) and migraine aura, with hormonal contraception showing potential benefits.

More Related Videos

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

8.6K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

19.1K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

8.6K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Women's Health

Background:

  • Migraine prevalence is higher in women, particularly during reproductive years.
  • Sex hormones, especially estrogen, play a significant role in migraine pathophysiology.
  • Brain imaging studies reveal sex-based differences in migraine patients.

Purpose of the Study:

  • To review the relationship between estrogen and migraine.
  • To focus on recent studies (last 18 months) investigating this connection.
  • To explore the impact of hormonal changes on migraine frequency and characteristics.

Main Methods:

  • Systematic and critical review of recent scientific literature.
  • Analysis of functional MRI (fMRI) studies on brain differences.
  • Examination of data on endogenous and exogenous sex hormone effects.

Main Results:

  • Estrogen level drops are linked to increased migraine risk, especially menstrually related migraine (MRM).
  • Reducing the magnitude of estrogen decline can prevent MRM and migraine aura.
  • Hormonal contraception may decrease headache and aura frequency in some women.

Conclusions:

  • Estrogen significantly influences migraine, particularly in women.
  • Minimizing estrogen decline is a potential strategy for preventing MRM.
  • Further research into hormonal therapies may offer new migraine management options.